Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 28.
doi: 10.1002/jso.25963. Online ahead of print.

Predictors of Lymph Node Metastases in Patients With Mucinous Appendiceal Adenocarcinoma

Affiliations

Predictors of Lymph Node Metastases in Patients With Mucinous Appendiceal Adenocarcinoma

Adrienne B Shannon et al. J Surg Oncol. .

Abstract

Background: Lymph node metastasis (LN+) is a prognostic factor in appendiceal cancers, but predictors and outcomes for LN+ in mucinous appendiceal adenocarcinoma (MAC) remain poorly defined.

Methods: Patients were identified from the 2010 to 2016 NCDB who underwent surgical resection as first-line management for Stage I-III mucinous appendiceal cancer. A LN+ risk-score model was developed using multivariable regression on a training data set and internally validated using a testing data set. Three-year overall survival (OS) was analyzed by Cox proportional hazards regression.

Results: Of 1158 patients, LN+ (N = 244, 21.1%) patients were more likely to have higher pT group and grade of disease, lymphovascular invasion (LVI), and positive margins on univariate analyses. Predictive factors associated with LN+ on multivariable analysis included positive surgical margins (odds ratio [OR] 3.00, P <.0001), higher grade (moderately differentiated: OR, 2.16, P < .0001; poorly or undifferentiated: OR, 3.07, P < .0001), and LVI (OR, 7.28, P < .0001). A validated risk-score model using these factors was developed with good performance (AUC 0.749). LN+ patients had a worse 3-year OS compared with LN- patients (17.4% vs 82.6%, hazard ratio 1.96, P = .001).

Conclusions: LN+ is associated with worse survival in patients with MAC. A risk-score model using margin status, LVI, and grade can accurately risk stratify patients for LN+.

Keywords: appendix cancer; lymph node harvest; lymph node metastases; positive lymph nodes; risk-score model; surgical oncology; surgical outcomes.

Similar articles

See all similar articles

References

REFERENCES

    1. Marmor S, Portschy PR, Tuttle TM, Virnig BA. The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg. 2015;19:743-750.
    1. Mo S, Zhou Z, Ying Z, et al. Epidemiology of and prognositic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Col Dis. 2019;34:1915-1924.
    1. Xie GD, Liu YR, Jiang YZ, Shao ZM. Epidemiology and survival outcomes of mucinous adenocarcinomas: a SEER population-based study. Sci Rep. 2018;8(1):6117.
    1. Kelly KJ. Management of appendix cancer. Clin Colon Rectal Surg. 2015;28:247-255.
    1. Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T. Improved survival after retrieveal of 12 or more regional lymph nodes in appendiceal cancer. Eur J Surg Oncol. 2017;43:1876-1885.

LinkOut - more resources

Feedback